Synthesis, Structure and Anticancer Activity of a Dinuclear Organoplatinum(IV) Complex Stabilized by Adenine

Alisha M. O’Brien,William A. Howard,Kraig A. Wheeler
DOI: https://doi.org/10.1101/2024.02.14.580361
2024-02-18
Abstract:The dinuclear organoplatinum(IV) compound {Pt(CH ) } (μ-I) (μ-adenine) (abbreviated ), obtained by treating cubic [Pt(CH ) (μ -I)] with two equivalents of adenine, was isolated and structurally characterized by single crystal X-ray diffraction. The National Cancer Institute Developmental Therapeutics Program’s sulforhodamine B assays showed to be particularly cytotoxic against central nervous system cancer cell line SF-539, and human renal carcinoma cell line RXF-393. Furthermore, displayed some degree of cytotoxicity against non-small cell lung cancer (NCI-H522), colon cancer (HCC-2998, HCT-116, HT29, and SW-620), melanoma (LOX-IMVI, MALME-3M, M14, MDA-MB-435, SK-MEL-28, and UACC-62), ovarian cancer (OVCAR-5), renal carcinoma (A498), breast cancer (BT-549 and MDA-MB-468), and triple-negative breast cancer (MDA-MB-231).
Cancer Biology
What problem does this paper attempt to address?